Skip to the page

Data / Form D filings / NovaDerm Aid Fund Omega LLC

NovaDerm Aid Fund Omega LLC: Form D filing

NovaDerm Aid Fund Omega LLC, a biotechnology company in Dallas, TX, filed a Form D with the SEC in 2023. The latest, on August 30, 2023, reports $675,000 sold of a $2 million offering to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4514 COLE AVENUE, SUITE 600, Dallas, TX, 75205
Phone
(214) 687-8437
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Nevada
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(c)
SEC identifier (CIK)
1991666

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 30, 2023New notice$2,000,000$675,000$1,325,0006Aug 14, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Geoffrey C DietrichDirector
Biomed Management Alpha LLCDirector
Beckett C CantleyDirector
Mark C BianchiDirector
Cirrus Investments C LLCPromoter

Other biotechnology companies in Texas that filed recently

Every Form D from the week of Aug 28, 2023 · All recent filings in Texas · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what NovaDerm Aid Fund Omega LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.